Cancer Australia Research Initiative Targeted Call for Research: Early-Onset Cancer 2025
GO ID: GO7773
Agency: National Health and Medical Research Council (NHMRC)
Close Date & Time: 10-Sep-2025 5:00 pm (ACT Local Time)
Show close time for other time zones
Co-sponsored with: Cancer Australia
Internal Reference ID: CARI TCR: Early-Onset Cancer 2025
Primary Category: 231013 - Medical Research
Publish Date: 16-Jul-2025
Location: ACT, NSW, VIC, SA, WA, QLD, NT, TAS
Selection Process: Targeted or Restricted Competitive
FO Reference: CARI TCR: Early-Onset Cancer 2025
Description:
Cancer Australia has established the Cancer Australia Research Initiative (CARI), a new initiative designed to reflect the contemporary cancer research landscape and ensure alignment with the Australian Cancer Plan to fund cancer research in areas of unmet and emerging need. CARI is directed by Cancer Australia, jointly funded by NHMRC and designed in accordance with the NHMRC’s Targeted Calls for Research (TCR) model. CARI will be delivered annually as a series of one-time grant opportunities, commencing in 2025-26. Proposals will need to demonstrate translational potential, and build capacity in the cancer research workforce, including through opportunities for early to mid-career researchers.
Early-Onset Cancers – Identified Priority
Cancer Australia identified early-onset cancers (EOC) as a strategic priority due to its global rise and diverse tumour sub-types, requiring further research on environmental and genetic interactions. The first CARI TCR grant opportunity aims to:
• Enhance understanding of EOC and develop novel clinical approaches for earlier diagnosis and innovative models of care to ensure effective management for those affected by EOC
• Support programs that leverage existing, multidisciplinary, collaborative activities, and that are designed to link to enduring broader research initiatives, to inform policy and large scale, novel research for EOC in future. The first CARI TCR grant opportunity will be guided by strategic, long-term approaches to address the possible causes, pathogenesis, early recognition and diagnosis, as well as complexities of management and survivorship associated with EOC. Applications may focus on a single tumour sub-type or multiple tumour types. Proposals addressing cancers that have a greater burden of disease are encouraged.
Eligibility:
Applications will only be accepted from NHMRC approved Administering Institutions. A list of NHMRC approved Administering Institutions is available at:
NHMRC’s Administering Institutions | NHMRC
Applications must satisfy all the requirements set out in the Cancer Australia Research Initiative Targeted Call for Research: Early-Onset Cancer 2025 Guidelines.
Grant Activity Timeframe:
Outcomes: Grants to be announced in June 2026, and the research output will be delivered for up to 3 years from commencement of the grant.
Total Amount Available (AUD):
$7,000,000.00
Instructions for Application Submission:
Applications must be submitted electronically using Sapphire (unless otherwise advised by NHMRC).
Other Instructions:
Minimum data is due 17.00 (ACT local time)) on 27 August 2025
Addenda Available:
View Addenda
For grant queries, please refer to the official contact details:
NHMRC Research Help Centre
Phone:
1800 500 983
Email Address: [email protected]
Web Address: https://www.nhmrc.gov.au/funding/targeted-calls-research